The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Regulation of gene transcription of angiotensin II receptor subtypes in myocardial infarction.
Open accessAbstract
Increasing evidence suggests that angiotensin II (AngII) acts as a modulator for ventricular remodeling after myocardial infarction. Using competitive reverse-transcriptase polymerase chain reaction, nuclear runoff, and binding assays, we examined the regulation of AngII type 1a and 1b (AT1a-R and AT1b-R) and type 2 receptor (AT2-R) expression in the infarcted rat heart as well as the effects of AngII receptor antagonists. AT1a-R mRNA levels were increased in the infarcted (4.2-fold) and noninfarcted portions (2.2-fold) of the myocardium 7 d after myocardial infarction as compared with those in sham-operated controls, whereas AT1b-R mRNA levels were unchanged. The amount of detectable AT2-R mRNA increased in infarcted (3.1-fold) and noninfarcted (1.9-fold) portions relative to that in the control. The transcription rates for AT1a-R and AT2-R genes, determined by means of a nuclear runoff assay, were significantly increased in the infarcted heart. The AngII receptor numbers were elevated (from 12 to 35 fmol/mg protein) in the infarcted myocardium in which the increases in AT1-R and AT2-R were 3.2- and 2.3-fold, respectively, while the receptor affinity was unchanged. Therapy with AT1-R antagonist for 7 d reduced the increase in AT1-R and AT2-R expressions in the infarcted heart together with a decrease in blood pressure, whereas therapy with an AT2-R antagonist did not affect mRNA levels and blood pressure. Neither AT1-R nor AT2-R antagonists affected the infarct sizes. These results demonstrated that myocardial infarction causes an increase in the gene transcription and protein expression of cardiac AT1a-R and AT2-R, whereas the AT1b-R gene is unaffected, and that therapy with an AT1-R antagonist, but not with an AT2-R antagonist, is effective in reducing the increased expression of AngII receptor subtypes induced by myocardial infarction.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Pfeffer, M. A., Braunwald, E., Moyé, L. A., Basta, L., Brown, E. J., Cuddy, T. E., Davis, B. R., Geltman, E. M., Goldman, S., Flaker, G. C., et al. (1992) · New England Journal of Medicine · doi:10.1056/nejm199209033271001 · Cited by 5,911
Pfeffer, M. A., & Braunwald, E. (1990) · Circulation · doi:10.1161/01.cir.81.4.1161 · Cited by 2,877
Wall stress and patterns of hypertrophy in the human left ventricle.
Grossman, W., Jones, D., & McLaurin, L. P. (1975) · Journal of Clinical Investigation · doi:10.1172/jci108079 · Cited by 2,403
Weber, K. T., & Brilla, C. G. (1991) · Circulation · doi:10.1161/01.cir.83.6.1849 · Cited by 2,027
Angiotensin II receptors and angiotensin II receptor antagonists.
Timmermans, P. B., Wong, P. C., Chiu, A. T., Herblin, W. F., Benfield, P., Carini, D. J., Lee, R. J., Wexler, R. R., Saye, J. A., & Smith, R. D. (1993) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)00446-6 · Cited by 1,853
Sadoshima, J., & Izumo, S. (1993) · Circulation Research · doi:10.1161/01.res.73.3.413 · Cited by 1,427
Sadoshima, J.-I., Xu, Y., Slayter, H. S., & Izumo, S. (1993) · Cell · doi:10.1016/0092-8674(93)90541-w · Cited by 1,348
Isolation of a cDNA encoding the vascular type-1 angiotensin II receptor
Murphy, T. J., Alexander, R. W., Griendling, K. K., Runge, M. S., & Bernstein, K. E. (1991) · Nature · doi:10.1038/351233a0 · Cited by 1,252
Effect of Captopril on Progressive Ventricular Dilatation after Anterior Myocardial Infarction
Pfeffer, M. A., Lamas, G. A., Vaughan, D. E., Parisi, A. F., & Braunwald, E. (1988) · New England Journal of Medicine · doi:10.1056/nejm198807143190204 · Cited by 1,103
Identification of angiotensin II receptor subtypes
Chiu, A. T., Herblin, W. F., McCall, D. E., Ardecky, R. J., Carini, D. J., Duncia, J. V., Pease, L. J., Wong, P. C., Wexler, R. R., Johnson, A. L., et al. (1989) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(89)91054-1 · Cited by 819
Sasaki, K., Yamano, Y., Bardhan, S., Iwai, N., Murray, J. J., Hasegawa, M., Matsudat, Y., & lnagami, T. (1991) · Nature · doi:10.1038/351230a0 · Cited by 811
Mukoyama, M., Nakajima, M., Horiuchi, M., Sasamura, H., Pratt, R. E., & Dzau, V. J. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)74498-6 · Cited by 768
Kambayashi, Y., Bardhan, S., Takahashi, K., Tsuzuki, S., Inui, H., Hamakubo, T., & Inagami, T. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)74499-8 · Cited by 714
Remodeling of the rat right and left ventricles in experimental hypertension.
Brilla, C. G., Pick, R., Tan, L. B., Janicki, J. S., & Weber, K. T. (1990) · Circulation Research · doi:10.1161/01.res.67.6.1355 · Cited by 674
Schunkert, H., Dzau, V. J., Tang, S. S., Hirsch, A. T., Apstein, C. S., & Lorell, B. H. (1990) · Journal of Clinical Investigation · doi:10.1172/jci114924 · Cited by 606
Eaton, L. W., Weiss, J. L., Bulkley, B. H., Garrison, J. B., & Weisfeldt, M. L. (1979) · New England Journal of Medicine · doi:10.1056/nejm197901113000202 · Cited by 551
Expression of AT2 receptors in the developing rat fetus.
Grady, E. F., Sechi, L. A., Griffin, C. A., Schambelan, M., & Kalinyak, J. E. (1991) · Journal of Clinical Investigation · doi:10.1172/jci115395 · Cited by 535
Cardiac Actions of Angiotensin II: Role of an Intracardiac Renin-Angiotensin System
Baker, K. M., Booz, G. W., & Dostal, D. E. (1992) · Annual Review of Physiology · doi:10.1146/annurev.ph.54.030192.001303 · Cited by 517
Fishbein, M. C., Maclean, D., & Maroko, P. R. (1978) · PubMed · Cited by 462
Tissue-specific activation of cardiac angiotensin converting enzyme in experimental heart failure.
Hirsch, A. T., Talsness, C. E., Schunkert, H., Paul, M., & Dzau, V. J. (1991) · Circulation Research · doi:10.1161/01.res.69.2.475 · Cited by 458
Schibler, U., Hagenbüchle, O., Wellauer, P. K., & Pittet, A. C. (1983) · Cell · doi:10.1016/0092-8674(83)90431-2 · Cited by 450
Renin-angiotensin system involvement in pressure-overload cardiac hypertrophy in rats
Baker, K. M., Chernin, M. I., Wixson, S. K., & Aceto, J. F. (1990) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.1990.259.2.h324 · Cited by 410
Angiotensin II is mitogenic in neonatal rat cardiac fibroblasts.
Schorb, W., Booz, G. W., Dostal, D. E., Conrad, K. M., Chang, K. C., & Baker, K. M. (1993) · Circulation Research · doi:10.1161/01.res.72.6.1245 · Cited by 391
Identification of functional angiotensin II receptors on rat cardiac fibroblasts.
Villarreal, F. J., Kim, N. N., Ungab, G. D., Printz, M. P., & Dillmann, W. H. (1993) · Circulation · doi:10.1161/01.cir.88.6.2849 · Cited by 369
Olivetti, G., Capasso, J. M., Sonnenblick, E. H., & Anversa, P. (1990) · Circulation Research · doi:10.1161/01.res.67.1.23 · Cited by 344 · cited 1×
“The myocardium remote from the area of infarction is subjected to increased diastolic wall stress (2, 3), resulting in myocyte slippage (3) as well as myocyte hypertrophy (4).”
BackgroundAngiotensin II type-1 receptor subtype cDNAs: Differential tissue expression and hormonal regulation
Kakar, S. S., Sellers, J. C., Devor, D. C., Musgrove, L. C., & Neill, J. D. (1992) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(05)80302-x · Cited by 326
Wong, P. C., Hart, S. D., Zaspel, A. M., Chiu, A. T., Ardecky, R. J., Smith, R. D., & Timmermans, P. B. (1990) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)23123-8 · Cited by 295
Suzuki, J., Matsubara, H., Urakami, M., & Inada, M. (1993) · Circulation Research · doi:10.1161/01.res.73.3.439 · Cited by 283
Self-citationAugmented expression of atrial natriuretic polypeptide gene in ventricle of human failing heart.
Saito, Y., Nakao, K., Arai, H., Nishimura, K., Okumura, K., Obata, K., Takemura, G., Fujiwara, H., Sugawara, A., & Yamada, T. (1989) · Journal of Clinical Investigation · doi:10.1172/jci113872 · Cited by 237
Transforming Growth Factor Beta-1 in Acute Myocardial Infarction in Rats
Thompson, N. L., Bazoberry, F., Speir, E. H., Casscells, W., Ferrans, V. J., Flanders, K. C., Kondaiah, P., Geiser, A. G., & Sporn, M. B. (1988) · Growth Factors · doi:10.3109/08977198809000251 · Cited by 231
Changes in expression of angiotensin receptor subtypes in the rat aorta during development
Viswanathan, M., Tsutsumi, K., Correa, F. M. A., & Saavedra, J. M. (1991) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(91)91723-p · Cited by 206
Lindpaintner, K., Lu, W., Niedermajer, N., Schieffer, B., Just, H., Ganten, D., & Drexler, H. (1993) · Journal of Molecular and Cellular Cardiology · doi:10.1006/jmcc.1993.1017 · Cited by 194
Regulation of angiotensin II receptors on ventricular myocytes after myocardial infarction in rats.
Meggs, L. G., Coupet, J., Huang, H., Cheng, W., Li, P., Capasso, J. M., Homcy, C. J., & Anversa, P. (1993) · Circulation Research · doi:10.1161/01.res.72.6.1149 · Cited by 178
Global cardiac remodeling after acute myocardial infarction: A study in the rat model
Weisman, H. F., Bush, D. E., Mannisi, J. A., & Bulkley, B. H. (1985) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(85)80348-x · Cited by 174
VANKRIMPEN, C., Smits, J. F. M., Cleutjens, J. P. M., Debets, J., Schoemaker, R. G., Struijker-Boudier, H. A. J., Bosman, F. T., & Daemen, M. J. A. P. (1991) · Journal of Molecular and Cellular Cardiology · doi:10.1016/0022-2828(91)90082-w · Cited by 154
Left ventricular failure induced by myocardial infarction. I. Myocyte hypertrophy
Anversa, P., Loud, A. V., Levický, V., & Guideri, G. (1985) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.1985.248.6.h876 · Cited by 149
Raya, T. E., Gay, R. G., Aguirre, M. A., & Goldman, S. (1989) · Circulation Research · doi:10.1161/01.res.64.2.330 · Cited by 146
Mori, Y., Matsubara, H., Folco, E. J. E., Siegel, A., & Koren, G. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)74340-3 · Cited by 108
Self-citationANG II receptors, c-myc, and c-jun in myocytes after myocardial infarction and ventricular failure
Krzysztof Reiss, F., Capasso, J. M., Huang, H. E., Meggs, L. G., Li, P., & Anversa, P. (1993) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.1993.264.3.h760 · Cited by 91
Murasawa, S., Matsubara, H., Urakami, M., & Inada, M. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)74209-4 · Cited by 54
Self-citationMeggs, L. G., Tillotson, J. K., Huang, H., Sonnenblick, E. H., Capasso, J. M., & Anversa, P. (1990) · Journal of Clinical Investigation · doi:10.1172/jci114861 · Cited by 20
Mori, Y., Nishikawa, M., Matsubara, H., Takagi, T., Toyoda, N., Oikawa, S., & Inada, M. (1990) · Endocrinology · doi:10.1210/endo-126-1-466 · Cited by 17
Self-citation
Cited by
International Union of Pharmacology. XXIII. The Angiotensin II Receptors
de Gasparo, M., Catt, K. J., Inagami, T., Wright, J. W., & Unger, T. (2000) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01458-3 · Cited by 2,132
Molecular Mechanisms of Myocardial Remodeling
SWYNGHEDAUW, B. (1999) · Physiological Reviews · doi:10.1152/physrev.1999.79.1.215 · Cited by 1,460
Behavioural and cardiovascular effects of disrupting the angiotensin II type-2 receptor gene in mice
Hein, L., Barsh, G. S., Pratt, R. E., Dzau, V. J., & Kobilka, B. K. (1995) · Nature · doi:10.1038/377744a0 · Cited by 742
Nakajima, M., Hutchinson, H. G., Fujinaga, M., Hayashida, W., Morishita, R., Zhang, L., Horiuchi, M., Pratt, R. E., & Dzau, V. J. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.23.10663 · Cited by 680
Liu, Y. H., Yang, X. P., Sharov, V. G., Nass, O., Sabbah, H. N., Peterson, E., & Carretero, O. A. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119360 · Cited by 603
Metadata
- Authors
- Nio, Y., Matsubara, H., Murasawa, S., Kanasaki, M., & Inada, M.
- Venue
- Journal of Clinical Investigation
- Published
- 1995-01-01
- Volume
- 95
- Issue
- 1
- Pages
- 46-54
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W2149060182
- Cited by
- 435
- References
- 42
- FWCI
- 27.46
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.